Linear atrophoderma of Moulin

From WikiMD's WELLNESSPEDIA

(Redirected from Moulin atrophoderma linearis)


Linear atrophoderma of Moulin
Synonyms
Pronounce N/A
Specialty Dermatology
Symptoms Hyperpigmentation, atrophy
Complications N/A
Onset Childhood or adolescence
Duration Chronic
Types N/A
Causes Unknown
Risks
Diagnosis Clinical diagnosis
Differential diagnosis Linear scleroderma, Morphea
Prevention N/A
Treatment None specific
Medication N/A
Prognosis Generally benign
Frequency Rare
Deaths N/A


Linear Atrophoderma of Moulin is a rare, idiopathic, acquired, linear dermatosis that was first described by Moulin et al. in 1992. It is characterized by hyperpigmented, atrophic, linear bands that follow the lines of Blaschko. The onset is usually in childhood or early adolescence. The pathogenesis of this condition is unknown.

Clinical Features[edit]

The clinical features of Linear Atrophoderma of Moulin include the following:

  • Onset: The onset is usually in childhood or early adolescence.
  • Lesions: The lesions are hyperpigmented, atrophic, linear bands that follow the lines of Blaschko.
  • Distribution: The distribution of the lesions is usually unilateral and segmental. The trunk and limbs are the most commonly affected areas.
  • Symptoms: The condition is usually asymptomatic.

Diagnosis[edit]

The diagnosis of Linear Atrophoderma of Moulin is primarily clinical, based on the characteristic appearance of the lesions and their distribution. Histopathological examination of the lesions shows a decrease in the amount of subcutaneous fat and dermal collagen, with no inflammation or changes in the overlying epidermis.

Treatment[edit]

There is no specific treatment for Linear Atrophoderma of Moulin. Management is primarily supportive, with the aim of improving the cosmetic appearance of the lesions. Options may include the use of topical corticosteroids, calcineurin inhibitors, and cosmetic camouflage.

Prognosis[edit]

The prognosis of Linear Atrophoderma of Moulin is generally good. The condition is not associated with any systemic involvement or malignancy. However, the cosmetic impact of the lesions can be significant.

See Also[edit]

References[edit]


Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Linear_atrophoderma_of_Moulin&oldid=6542669"